← Back to Stocks

MDT - Medtronic plc

In Value Zone (< 200W SMA)
Health Care
Dividend Aristocrat

Price History

About

Industry

Medical Devices

Employees

95,000

Headquarters

Ireland


Company Overview

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Price

$83.19

52-Week Range

$73 $106

Dividend Yield

3.64%

Dividend Score

B

Dividend

Yield 3.64%
Annual $2.88
Payout 76%
5Y Avg 3.00%

Valuation

P/E (TTM) 22.3
Fwd P/E 13.0
P/B 2.15
PEG 1.56

Profitability

Profit Margin 13.2%
Op Margin 22.0%
ROE 9.8%
ROA 4.9%

Financial Health

Current Ratio 2.13
Quick Ratio 1.36
Debt/Equity 58%

Cash Flow

Free CF $4.6B
Op CF $7.3B
Total Cash $9.2B

Performance (12M)

Price Change -5.77%
Total Return -2.55%

Analyst Consensus

Buy

26 analysts

Target: $98 $78 - $121
+17.5% implied

Annual Return Breakdown

Dividend Growth

Most Recent Annual Growth

1.43%

3-Year Avg Growth

1.96%

5-Year Avg Growth

4.46%

Annual Dividends

Year-over-Year Growth

Recent Dividend History

Ex-Dividend Date Amount
Jun 26, 2026 $0.7200
Mar 27, 2026 $0.7100
Dec 26, 2025 $0.7100
Sep 26, 2025 $0.7100
Jun 27, 2025 $0.7100
Mar 28, 2025 $0.7000
Dec 27, 2024 $0.7000
Sep 27, 2024 $0.7000
Jun 28, 2024 $0.7000
Mar 21, 2024 $0.6900
Dec 19, 2023 $0.6900
Sep 21, 2023 $0.6900
Jun 22, 2023 $0.6900
Mar 23, 2023 $0.6800
Dec 20, 2022 $0.6800
Sep 22, 2022 $0.6800
Jun 23, 2022 $0.6800
Mar 24, 2022 $0.6300
Dec 21, 2021 $0.6300
Sep 23, 2021 $0.6300